Earnings History Data for Corvus Pharmaceuticals, Inc. (CRVS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-08-2022 AH 4:05 PM ET
(Aug 8)
CRVS Corvus Pharmaceuticals, Inc. 44.92 -0.18 -0.19 -0.28 Corvus Pharmaceuticals GAAP EPS of -$0.18 in-line
[8/8/2022 4:22 PM]
0.8797 -0.08 
(-8.36%)
0.92 -0.04 
(-4.69%)
0.75 - 9.54 743,351 350,000 6,345
10-03-2022 AH 4:05 PM ET
(Mar 10)
CRVS Corvus Pharmaceuticals, Inc. 71.22 -0.20 -0.20 -0.35 Corvus Pharmaceuticals GAAP EPS of -$0.20 misses by $0.01
[3/10/2022 4:14 PM]
1.51 -0.08 
(-4.86%)
1.60 0.01 
(0.63%)
1.50 - 9.54 217,883 150,000 1,862
01-11-2021 AH 4:05 PM ET
(Nov 1)
CRVS Corvus Pharmaceuticals 196.00 -0.24 -0.30 0.00 Corvus Pharmaceuticals EPS misses by $0.03
[11/1/2021 5:14 PM]
4.96 0.13 
(2.69%)
4.80 -0.03 
(-0.62%)
1.86 - 9.54 1,087,011 680,000 23,715
02-08-2021 AH CRVS Corvus Pharmaceuticals, Inc. 83.00 -0.28 -0.32 0.00 Corvus Pharmaceuticals EPS in-line
[8/2/2021 4:40 PM]
2.10 -0.04 
(-1.87%)
2.14 0.0 
(0.00%)
2.04 - 5.74 278,918 310,000 101
29-04-2021 AH After the close
(Apr 29)
CRVS Corvus Pharmaceuticals, Inc. 107.65 -0.34 -0.33 -0.44 Corvus Pharmaceuticals EPS misses by $0.04
[4/29/2021 4:52 PM]
2.81 -0.01 
(-0.35%)
2.90 0.08 
(2.84%)
2.12 - 6.88 96,133 180,000 703
25-03-2021 PM CRVS Corvus Pharmaceuticals, Inc. 124.89 -0.35 -0.32 -0.38 Corvus Pharmaceuticals EPS beats by $1.16
[3/25/2021 8:59 AM]
3.10 0.24 
(8.39%)
2.86 0.0 
(0.00%)
1.91 - 6.88 471,363 570,000 16,472
29-10-2020 AH CRVS Corvus Pharmaceuticals, Inc. 115.00 -0.33 -0.25 0.00 Corvus Pharmaceuticals EPS misses by $0.06
[10/29/2020 4:58 PM]
3.91 -0.08 
(-2.00%)
3.96 -0.03 
(-0.75%)
1.01 - 6.88 143,437 164,799 301